Randomized Open Labeled Clinical Trial: a Comparative Study of 10-day High Dose PPI-based Triple Therapy vs. 10-day Sequential Therapy for Helicobacter Pylori Eradication in Functional Dyspepsia Patients

NCT01888237 Phase 4 COMPLETED

The purpose of this study is to compare the efficacy between 1-day high dose PPI-based triple therapy vs. 10-day sequential therapy for Helicobacter pylori eradication in functional dyspepsia patients.

Details

Lead sponsor	Mahidol University
Phase	Phase 4
Status	COMPLETED
Enrolment	118
Start date	2013-05
Completion	2014-09

Conditions

• Dyspepsia
• Helicobacter-associated Gastritis
• Stomach Disorders

Interventions

• Double dose of PPI
• sequence of drug use

Primary outcomes

• Eradication rate — 4 weeks after the end of intervention

Countries

Thailand